BelVituniPharm Investment Project Until 2030

BelVituniPharm plans to complete its project for the production of medical and veterinary vaccines, and biotechnological drugs, by 2030, BelTA notifies.

The plans include building a vaccine production plant, commissioning equipment for recombinant drugs, and establishing a facility for anti-cancer medicines.

Funding will come from domestic sources without foreign investors to ensure the country’s biological security.

Follow us on Facebook, LinkedIn!

Photo: freepik.com